Emerging from the UK, retatrutide, a novel peptide , is creating considerable buzz within the healthcare community regarding its potential for physique control . This dual GIP and GLP-1 agent agonist seems to offer a substantial improvement over current therapies, showing positive results in preliminary clinical studies . Researchers suggest its di